Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A randomized, placebo-controlled, double blind, multiple ascending dose, phase 1 study to evaluate the safety, tolerability, and pharmacokin… Ended

2024-513127-16-00 NA - healthy volunteers 2024-06-24
Evaluation of irritation potential of topical formulations on intact skin Ended

2024-511826-29-00 Dermal tolerability test: Testing for non-specific, loc 2024-06-20
An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants with Schizophrenia Ended

2023-505664-11-00 Schizophrenia 2024-06-19
An Open-label, Single-dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-77242113 in Adult Participants Ended

2023-510161-97-00 Renal Impairment 2024-06-19
A randomized, single dose, cross-over bioavailability study comparing the drug-drug interaction between telmisartan tablets, indapamide tabl… Ended

2024-510835-23-00 high blood pressure 2024-06-19
A Phase 1, Open-Label Study to Investigate the TARP-ɣ8 Receptor Occupancy of RAP-219 Using a TARP-γ8 PET Tracer in Healthy Adult Participant… Ended

2024-512151-21-00 Epilepsy 2024-06-19
Comparison of the study drug CHF 1535 formulated with two different propellants to learn about drug levels in blood and safety after inhalat… Ended

2023-510171-59-00 Asthma and chronic obstructive pulmonary disease (COPD) 2024-06-17
A Phase 1b, Open-Label, Single-Arm Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of ANX15… Ended

2023-507017-10-00 Primary Cold Agglutinin Disease (CAD) 2024-06-17
An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation Ended

2023-507630-25-00 Infertility in women undergoing assisted reproductive t 2024-06-14
A Phase 1, Randomized, Open Label, Single-Dose Crossover Study to Assess the Relative Bioavailability, Food Effect, and Safety of Capsule Fo… Ended

2024-510915-31-00 Not applicable, healthy volunteers 2024-06-14
A Phase 1, 2-part, open-label, single-sequence study to investigate the effect of single and multiple doses of obefazimod on the pharmacokin… Ended

2023-509226-21-00 Moderately to severely active ulcerative colitis 2024-06-13
Comparative Pharmacokinetic of S221237 Tablets in Healthy Participants Under Fed Conditions Ended

2024-511270-72-00 No medical condition 2024-06-13
A Phase I, open-label, randomized, two period, cross-over study in healthy subjects to assess the bioavailability of different formulations … Ended

2024-511196-15-00 Hereditary angioedema (HAE) 2024-06-13
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHAR… Ended

2023-510247-38-00 Rheumatoid arthritis 2024-06-07
MK-7091 Formulations Study in Healthy Adult Participants Ended

2023-510402-40-00 Hypercholesterolemia 2024-06-07
Study to evaluate the pharmacokinetics, safety and tolerability of Secukinumab in patients with GCA or PMR Ended

2023-507667-19-00 Polymyalgia rheumatica (PMR) 2024-06-06
A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without rabeprazole. Ended

2023-510467-35-00 Healthy Adult Participants. 2024-06-05
A study to learn how vamorolone affects the body, how safe it is and how it moves into, through and out of the body in healthy male particip… Ended

2024-512101-60-00 Phase I study in healthy male volunteers. Intended indi 2024-06-05
Multiple Ascending Doses of BMS-986326 in Participants with Discoid Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus, or Systemic… Ended

2022-503009-39-00 Subacute Cutaneous Lupus Erythematosus 2024-06-04
A study in healthy people to test how BI 1015550 is taken up in the body when given with or without food Ended

2023-509889-38-00 Healthy volunteer trial 2024-05-28
Intradermal LPS to study vascular responses Ended

2024-512377-27-00 Immunological/cardiovascular conditions 2024-05-28
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months Ended

2022-502022-41-00 Acute lower respiratory infection 2024-05-28
A two-part trial in healthy volunteers to find out how long JNJ-77242113 stays in and acts on the body when administered as different tablet… Ended

2024-512220-11-00 Inflammatory Conditions 2024-05-23
A study to compare the pharmacokinetics of salbutamol administered via metered dose inhalers containing propellants HFA-152a (test) or HFA-1… Ended

2023-508279-36-00 Healthy volunteers 2024-05-22